ReviewChinese medical journal2020

Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1.

Jing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.